Literature DB >> 28729028

MicroRNAs as Key Effectors in the p53 Network.

Frauke Goeman1, Sabrina Strano1, Giovanni Blandino2.   

Abstract

The guardian of the genome p53 is embedded in a fine-spun network of MicroRNAs. p53 is able to activate or repress directly the transcription of MicroRNAs that are participating in the tumor-suppressive mission of p53. On the other hand, the expression of p53 is under tight control of MicroRNAs that are either targeting directly p53 or factors that are modifying its protein level or activity. Although the most important function of p53 is suggested to be transcriptional regulation, there are several nontranscriptional functions described. One of those regards the modulation of MicroRNA biogenesis. Wild-type p53 is increasing the maturation of selected MicroRNAs from the primary transcript to the precursor MiRNA by interacting with the Microprocessor complex. Furthermore, p53 is modulating the mRNA accessibility for certain MicroRNAs by association with the RISC complex and transcriptional regulation of RNA-binding proteins. In this way p53 is able to remodel the MiRNA-mRNA interaction network. As wild-type p53 is employing MicroRNAs to suppress cancer development, gain-of-function mutant p53 proteins use MicroRNAs to confer oncogenic properties like chemoresistance and the ability to drive metastasis. Like its wild-type counterpart mutant p53 is able to regulate MicroRNAs transcriptionally and posttranscriptionally. Mutant p53 affects the MiRNA processing at two cleavage steps through interfering with the Microprocessor complex and by downregulating Dicer and KSRP, a modulator of MiRNA biogenesis. Thus, MicroRNAs are essential components in the p53 pathway, contributing substantially to combat or enhance tumor development depending on the wild-type or mutant p53 context.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AGO; Gain of function; Metastasis; MicroRNA; MicroRNA biogenesis; MicroRNA maturation; Microprocessor complex; Mutant p53; Transcriptional regulation; Tumor suppressor; p53

Mesh:

Substances:

Year:  2017        PMID: 28729028     DOI: 10.1016/bs.ircmb.2017.04.003

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  16 in total

1.  Application of epigenetic data in human health risk assessment.

Authors:  Ila L Cote; Shaun D McCullough; Ronald N Hines; John J Vandenberg
Journal:  Curr Opin Toxicol       Date:  2017-11-06

2.  p53 Regulates a miRNA-Fructose Transporter Axis in Brown Adipose Tissue Under Fasting.

Authors:  Isabel Reinisch; Ingeborg Klymiuk; Helene Michenthaler; Elisabeth Moyschewitz; Markus Galhuber; Jelena Krstic; Magnus Domingo; Fangrong Zhang; Michael Karbiener; Nemanja Vujić; Dagmar Kratky; Renate Schreiber; Michael Schupp; Georgia Lenihan-Geels; Tim J Schulz; Roland Malli; Tobias Madl; Andreas Prokesch
Journal:  Front Genet       Date:  2022-06-06       Impact factor: 4.772

3.  Integrated analysis of miRNA and mRNA expression profiles in p53-edited PFF cells.

Authors:  Chuanmin Qiao; Weiwei Liu; Haoyun Jiang; Maozhang He; Qiang Yang; Yuyun Xing
Journal:  Cell Cycle       Date:  2020-03-26       Impact factor: 4.534

Review 4.  microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview.

Authors:  Martino Marco Gabra; Leonardo Salmena
Journal:  Front Oncol       Date:  2017-10-30       Impact factor: 6.244

Review 5.  Circular RNAs and their roles in head and neck cancers.

Authors:  Yang Guo; Jiechao Yang; Qiang Huang; Chiyao Hsueh; Juan Zheng; Chunping Wu; Hui Chen; Liang Zhou
Journal:  Mol Cancer       Date:  2019-03-21       Impact factor: 27.401

6.  The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.

Authors:  Marco Napoli; Elsa R Flores
Journal:  RNA Biol       Date:  2020-01-07       Impact factor: 4.652

7.  Hyperglycemia Affects miRNAs Expression Pattern during Adipogenesis of Human Visceral Adipocytes-Is Memorization Involved?

Authors:  Justyna Strycharz; Ewa Świderska; Adam Wróblewski; Marta Podolska; Piotr Czarny; Janusz Szemraj; Aneta Balcerczyk; Józef Drzewoski; Jacek Kasznicki; Agnieszka Śliwińska
Journal:  Nutrients       Date:  2018-11-15       Impact factor: 5.717

8.  Revealing a human p53 universe.

Authors:  Thuy-Ai T Nguyen; Sara A Grimm; Pierre R Bushel; Jianying Li; Yuanyuan Li; Brian D Bennett; Christopher A Lavender; James M Ward; David C Fargo; Carl W Anderson; Leping Li; Michael A Resnick; Daniel Menendez
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

Review 9.  The Impact of Mutant p53 in the Non-Coding RNA World.

Authors:  Silvia Di Agostino
Journal:  Biomolecules       Date:  2020-03-19

10.  Dasatinib plus quercetin prevents uterine age-related dysfunction and fibrosis in mice.

Authors:  Marcelo B Cavalcante; Tatiana D Saccon; Allancer D C Nunes; James L Kirkland; Tamara Tchkonia; Augusto Schneider; Michal M Masternak
Journal:  Aging (Albany NY)       Date:  2020-01-18       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.